|
V.TLT
|
The specialists involved in the research, preclinical work, etc, are too many...
|
|
V.TLT
|
Well then, they need to start making sure they are "known". Maybe...
|
|
V.TLT
|
I know the last 5 NRs have all been preclinical, so in theory they might not...
|
|
V.TLT
|
Seems like everyone thinks the "why" is to try to make the PP...
|
|
V.TLT
|
How is the tumor "treated" or inoculated? Is it an IV, and then X...
|
|
V.TLT
|
Surprised they'd release news on a US market holiday. Nice update though.
|
|
V.TLT
|
Ok fair enough. We'll see, and let's hope unomorethanalittle on this...
|
|
V.TLT
|
What makes you so sure that you know more than they do, and that it's a...
|
|
V.TLT
|
Isn't the answer potentially simpler than we're making it out to be...
|
|
V.TLT
|
Want to see an example of what TLT should be doing on these NRs? Check the...
|
|
V.TLT
|
@enrique, Thanks. Then maybe IV administration is all that's needed? Then...
|
|
V.TLT
|
To be more specific, it translates well in humans for NMIBC because the...
|
|
V.TLT
|
Maybe the big hangup with big pharma at this time is the questions around...
|
|
V.TLT
|
Haven't been following this for as long as some of you, but I haven't...
|
|
V.TLT
|
Thank you to captain obvious. Everyone here knows they're all waiting for...
|
|
V.TLT
|
I agree, that would make no sense. But like notpoop said, is it possible they...
|
|
V.TLT
|
You nailed my binary guess. Either an embarrassing fumble of a PP, similar to...
|
|
V.TLT
|
I don't really understand it. A NR just to "remind" everyone...
|
|
V.TLT
|
Sounds great. Hopefully the potential is actualized someday. Also wonder if...
|
|
V.TLT
|
We all know small pharma CEOs read bullboards. LOL
|